C3 Pushes Congressional Leaders to Improve the Pending Health Care Reform Bill

Today, C3 joined with twenty-one groups to send a letter to Congressional leaders about ways Congress can improve the final health care reform bill to make high quality and affordable health care available to cancer patients.

House and Senate Leadership were back at the White House today for another day-long negotiation session aimed at reconciling differences between the House-passed and Senate-passed bills.  President Obama is scheduled to met with Democrats this evening at the Democrats’ annual issues conference to talk about health care reform.

Congressional leaders are working to get a final compromise agreed to, and sent to the Congressional Budget Office (CBO) by Friday.  CBO will need 10-15 days to analyze the bill and put together a cost estimate.  Members want to see a final cost estimate and analysis before voting on the package.

The letter C3 sent asks Congress to:

Many colorectal cancer patients face a lifetime of cancer treatment.  Caps on insurance result in very difficult decisions about the care they will receive and how they are going to pay for it.

Eliminating pre-existing conditions exclusions is very important for cancer patients.  Pre-existing condition exclusions lock the millions of Americans with at least one chronic illness (nearly one third of the population) into existing plans and employment.

There are a number of additional provisions in both the House-passed and Senate-passed health care reform bills that will affect colorectal cancer patients.  Click here to see a chart outlining and comparing these provisions.

C3 will continue to work with legislators to advocate for improvements to the pending bills that will provide all Americans with the access to care that is critical to preventing, treating and beating colorectal cancer.

Please feel free to share your thoughts with us by leaving comments below.

Bookmark and Share

This news article was originally posted on January 14th, 2010 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Catherine Knowles on January 14th, 2010
Tags: Health Care Reform, House of Representatives, Senate

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Search C3

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.

First Name

Last Name

Email

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

Sign Our Petition

Guarantee access to colorectal cancer screening for all Americans who need it.

Get Involved

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe